Literature DB >> 23993374

Controversy in treatment of advanced ovarian cancer.

Giovanni Scambia1, Vanda Salutari, Giulia Amadio.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23993374     DOI: 10.1016/S1470-2045(13)70391-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Model-based meta-analysis for quantifying Paclitaxel dose response in cancer patients.

Authors:  D Lu; A Joshi; H Li; N Zhang; M M Ren; Y Gao; R Wada; J Y Jin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-05-21

2.  Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.

Authors:  Shuqing Li; Lina Yang; Jingshu Wang; Fan Liang; Bin Chang; Huafen Gu; Honglin Wang; Gong Yang; Yaping Chen
Journal:  Oncotarget       Date:  2016-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.